Rooted in ovarian health.
Changing the future of medicine.
Celmatix is a preclinical-stage biotech transforming women’s lives through better ovarian health.
One in three women have conditions caused by poor ovarian health.
Despite often debilitating symptoms, such conditions are still being treated with hormonal interventions introduced more than 50 years ago.
The problem doesn’t stop there. Because the ovary plays a critical role in overall endocrine function, women experience serious health problems when ovarian function fails.
We have decoded ovarian function, which lies at the center of a complex endocrine signaling network.
Read about us in:
Our discovery program
We’ve amassed the largest structured dataset on ovarian health and outcomes in the world. This proprietary resource will drive the next ten years of discovery in our field, and is already powering our retained and partnered drug programs.
This industry-leading program includes
Our pipeline
Our partnerships
We are partnered with industry leaders to discover and develop the next generation of women’s health therapeutics.